Results 31 to 40 of about 36,244 (312)
Zhongguo shuxue zazhi, 2023 Objective To determine the best collection time period of plasma which can be used for human COVID-19 immunoglobulin for intravenous injection through SARS-CoV-2-IgG change and neutralizing antibody distribution against different virus strain in ...
Zhijun ZHOU +12 more
doaj +1 more source
Immune responses to Sinopharm/
Immunology, 2022 Abstract As there are limited data of the immunogenicity of the Sinopharm/BBIBP‐CorV in different populations, antibody responses against different SARS‐CoV‐2 variants of concern and T cell responses, we investigated the immunogenicity of the vaccine, in individuals in Sri Lanka.
Jeewandara, C +31 more
openaire +3 more sources
Paracentral acute middle maculopathy and COVID‐19 vaccination: Causation versus coincidence finding
Clinical Case Reports, 2022 The current report is a rare case of paracentral acute middle maculopathy (PAMM) in a previously healthy man following COVID‐19 vaccination.
Alireza Dehghani +3 more
doaj +1 more source
Efficacy of Sinopharm Vaccine Among Healthcare Workers of Pakistan
Pakistan Journal of Medicine and Dentistry, 2022 Background: The advent of a vaccine for COVID-19 has been a breakthrough to prevent infection from the virus. The objective of this study was to compare the frequency and severity of COVID-19 infection among vaccinated and non-vaccinated healthcare workers (HCWs).
Faridah Amin +5 more
openaire +2 more sources
Ischemic stroke following COVID-19 vaccination [PDF]
Journal of Research in Clinical Medicine, 2023 Following the coronavirus disease 2019 (COVID-19) vaccination, complications are expected. In this regard, coagulopathy after COVID-19 vaccination has been reported.
Nooshin Masoudian +4 more
doaj +1 more source
Immunogenicity and Safety of Sinopharm Covid-19 Vaccine in Young Mice [PDF]
International Journal of Clinical Case Reports and Reviews, 2022 Background and Aim: Vaccines to prevent SARS-CoV-2 infection may be considered a promising way for reduction of the pandemic. Many different vaccines have become obtainable for use in many countries. The present study aims to evaluate the immune response and the safety of Sinopharm COVID-19 vaccine on 14 days old mice.
Abdul M Gbaj +10 more
openaire +1 more source
, 2021 Objectives: To determine the gender and age based disparities in side effects among healthcare workers in response to COVID-19 (Sinopharm) vaccination Subjects & Methods: Total 216 healthcare workers were vaccinated against COVID-19 by administering ...
Rizwana Shahid , Muhammad Umar , Muhammad Mujeeb Khan , Shazia Zeb , Ayesha Nadar ,Sheema Afzal
core +1 more source
, 2022 Additional file 1: Figure S1. Effects of the age and the sex of the subject, and the time-period between the vaccination and the measurement on the probability of the lack of RBD-specific antibody production (titre below 1) after two doses of the ...
Balázs Sarkadi (120135) +1 more
core +1 more source
Comparative evaluation of serological protection against SARS-CoV-2: sinopharm vaccine versus convalescent plasma [PDF]
, 2023 Introducere. Pandemia de COVID-19 a avut un impact global devastator. În acest context, disponibilitatea timpurie a vaccinurilor eficiente, cum ar fi Sinopharm, a fost esențială pentru gestionarea crizei. Scopul lucrării.
Ulinici, Mariana
core
Sobre eventos adversos de la vacuna contra la covid-19 de sinopharm
, 2021 Desde febrero de 2021 se inició el programa de vacunación del personal sanitario en el Perú 2 . Para dicho personal se ha destinado el antídoto de Sinopharm. En la presente carta científica reportamos las frecuencias con la que se presentaron los eventos
Aguirre-Siancas, E. +2 more
core +1 more source